Analysed MERCK KGAA (MKGAF:OTCMKTS) News Sources
Global Human Osteoblasts Market Report 2026 | Capitalize on $53.09 Billion Revenue Share by 2030 as Merck KGaA, Thermo Fisher Scientific, Lonza and STEMCELL Lead the Industry
21-10-2026
yahoo.com
Global Bioprocessing Reagent Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, Danaher, Merck KGaA and Sartorius Accelerate AI and Single-Use Systems
21-10-2026
yahoo.com
Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis
22-10-2026
yahoo.com
Stocktwits Biotech Dealmaker: Gilead And Roche Double Down On Early-Stage Assets Over Full Buyouts This Week
24-10-2026
stocktwits.com
ProtaGene Appoints Former Merck KGaA CDMO Leader Matthias Bucerius as Chief Executive Officer
27-10-2026
yahoo.com
MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea
29-10-2026
yahoo.com
Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics Workflows
29-10-2026
yahoo.com
What is the current price of MERCK KGAA (MKGAF:OTCMKTS)?
The current price of MERCK KGAA (MKGAF:OTCMKTS) is $169.25.
MERCK KGAA (MKGAF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MERCK KGAA (MKGAF:OTCMKTS) since the previous trading day is $0.04.
MERCK KGAA (MKGAF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MERCK KGAA (MKGAF:OTCMKTS) since the previous trading day is 0.0236%.
What is the most recent average sentiment score for MERCK KGAA (MKGAF:OTCMKTS)?
The most recent average sentiment score for MERCK KGAA (MKGAF:OTCMKTS) is 80 out of 100.
What is the most recent average sentiment for MERCK KGAA (MKGAF:OTCMKTS)?
The most recent sentiment for MERCK KGAA (MKGAF:OTCMKTS) is .
SEC-8K** Filing Available For MERCK KGAA (MKGAF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.